Technology Profiles
 Profile Detail
Thrombocyte therapy to repair connective tissue/ human skin, e.g. to treat dekubitus (09 DE 0957 3F05)
A German biotech company developed a standardised lotion with thrombocyte epidermal growth factors to treat chronic wounds like Ulcus cruris, arterial occlusion or dekubitus. The therapy with the invented solution supports the formation of connective tissue. Chronic wounds can heal faster and better. The company looks for partners with interest in using or adapting the method for commercial agreement with technical assistance and further development.
Country: Germany
Type: OFFER
Date: 18.08.2011
The German biotech company is specialised in developing technologies to treat human skin with methods that don't need any animal experiments, which are still common in the cosmetic and pharmaceutical industry.
The companies focus is the development of therapies allowing for the renewal of human skin, like for patients with burns or chronic wounds.
The newest invention is a lotion with thrombocyte epidermal growth factors to treat chronic wounds like Ulcus cruris, arterial occlusion or dekubitus. The therapy with the invented solution supports the formation of connective tissue. It supports actively the germination of new vessels, which is the best possible precondition for a complete and fully surfaced repair of the connective tissue.
Innovative Aspects:
- the treatment and handling is very compatible
- it's an easy, non- invasive procedure
- chronic wounds can heal faster and better
Degree of development:
Patents/Rights: Secret know-how
Requested Cooperation: License Agreement, Change in the partner sought's currently used technologies (installations, process, facilities), Absolutely novel process, Assembly, Engineering, Technical consultancy, Quality control, Maintenance, Joint further development, Testing of new applications, Adaptation to specific needs, Joint Venture Agreement, New way to use an existing production line, Transfer of knowledge in new raw materials
The company is looking for SMEs specialised in bio-medicine in order to implement the technology in their region and for medical research centres for further development of the therapy. The company is interested in starting contact to clinics/ hospitals to use the new methods for wound healing patients dekubitus, e.g.
Type of Organisation:
Status: NEW
| 
